Analyst Price Targets — NVST
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 8, 2026 1:15 pm | — | Evercore ISI | $30.00 | $26.66 | TheFly | Envista price target lowered to $30 from $32 at Evercore ISI |
| February 6, 2026 2:48 pm | — | Robert W. Baird | $30.00 | $28.37 | TheFly | Envista price target raised to $30 from $27 at Baird |
| February 6, 2026 1:40 pm | — | Morgan Stanley | $19.00 | $28.09 | TheFly | Envista price target raised to $19 from $18 at Morgan Stanley |
| February 6, 2026 1:25 pm | Elizabeth Anderson | Evercore ISI | $32.00 | $28.44 | TheFly | Envista price target raised to $32 from $26 at Evercore ISI |
| February 6, 2026 12:29 pm | — | Stifel Nicolaus | $31.00 | $24.71 | TheFly | Envista price target raised to $31 from $27 at Stifel |
| February 6, 2026 11:54 am | Jason Bednar | Piper Sandler | $25.00 | $24.71 | TheFly | Envista price target raised to $25 from $21 at Piper Sandler |
| February 6, 2026 11:36 am | — | Leerink Partners | $35.00 | $24.71 | TheFly | Leerink upgrades Envista to Outperform on improved growth, execution |
| February 4, 2026 1:09 pm | Jonathan Block | Stifel Nicolaus | $27.00 | $23.28 | TheFly | Envista price target raised to $27 from $25 at Stifel |
| February 3, 2026 12:16 pm | Kevin Caliendo | UBS | $25.00 | $23.26 | TheFly | Envista price target raised to $25 from $22 at UBS |
| January 30, 2026 11:56 am | — | Piper Sandler | $21.00 | $23.39 | TheFly | Envista price target raised to $21 from $19 at Piper Sandler |
Latest News for NVST
BREA, Calif., April 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2026 on Wednesday, May 6, 2026.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Envista Holdings Corporation's NVST strategic priorities position it for robust growth in the upcoming quarters. The company is positioned to benefit from favorable long-term dental industry trends.
Envista NVST shares have climbed 42.5% over the past year, showcasing impressive momentum. The stock has outpaced the industry's 22.5% decline and the S&P 500 composite's 16.6% gain.
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NVST.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.